Epidermal powder immunization of mice and monkeys with an influenza vaccine

By Chen D.   Endres R.   Maa Y.-F.   Kensil C.R.   Whitaker-Dowling P.   Trichel A.   Youngner J.S.   Payne L.G.  

Vaccine, Vol. 21, Iss. 21, 2003-06 ,pp. : 2830-2836

Elsevier

Access to resources Recommend Favorite

Influenza virus neutralizing antibodies and IgG isotype profiles after immunization of mice with influenza A subunit vaccine using various adjuvants

By Benne C.A.   Harmsen M.   van der Graaff W.   Verheul A.F.M.   Snippe H.   Kraaijeveld C.A.  

Vaccine, Vol. 15, Iss. 9, 1997-06 ,pp. : 1039-1044

Elsevier

Access to resources Recommend Favorite

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

By Kilbourne E.D.   Couch R.B.   Kasel J.A.   Keitel W.A.   Cate T.R.   Quarles J.H.   Grajower B.   Pokorny B.A.   Johansson B.E.  

Vaccine, Vol. 13, Iss. 18, 1995-01 ,pp. : 1799-1803

Elsevier

Access to resources Recommend Favorite

Intranasal immunization with formalin-inactivated virus vaccine induces a broad spectrum of heterosubtypic immunity against influenza A virus infection in mice

By Takada A.   Matsushita S.   Ninomiya A.   Kawaoka Y.   Kida H.  

Vaccine, Vol. 21, Iss. 23, 2003-07 ,pp. : 3212-3218

Elsevier

Access to resources Recommend Favorite

Response to influenza vaccine in people with non-protective HI antibody titers

By Baldo Vincenzo   Baldovin Tatjana   Floreani Annarosa   Minuzzo Michele   Trivello Renzo  

European Journal of Epidemiology, Vol. 21, Iss. 11, 2006-11 ,pp. : 843-845

Springer Publishing Company

Access to resources Recommend Favorite